Murielle Mauer

9.6k total citations · 5 hit papers
86 papers, 5.8k citations indexed

About

Murielle Mauer is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Murielle Mauer has authored 86 papers receiving a total of 5.8k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Oncology, 39 papers in Pulmonary and Respiratory Medicine and 25 papers in Surgery. Recurrent topics in Murielle Mauer's work include Colorectal Cancer Treatments and Studies (32 papers), Gastric Cancer Management and Outcomes (22 papers) and Hepatocellular Carcinoma Treatment and Prognosis (15 papers). Murielle Mauer is often cited by papers focused on Colorectal Cancer Treatments and Studies (32 papers), Gastric Cancer Management and Outcomes (22 papers) and Hepatocellular Carcinoma Treatment and Prognosis (15 papers). Murielle Mauer collaborates with scholars based in Belgium, Netherlands and Germany. Murielle Mauer's co-authors include Bernard Nordlinger, Eric Van Cutsem, Wolf O. Bechstein, Andrew Bottomley, Corneel Coens, Manfred P. Lutz, David Osoba, Graeme J. Poston, Laurence Collette and Peter M. Schlag and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Murielle Mauer

81 papers receiving 5.7k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial

2013 853 citations Bernard Nordlinger, Halfdan Sørbye et al. The Lancet Oncology profile →
Duration of Androgen Suppression in the Treatment of Prostate Cancer

2009 658 citations M. Bolla, Geertjan van Tienhoven et al. New England Journal of Medicine profile →
Neoadjuvant Chemotherapy Compared With Surgery Alone for Locally Advanced Cancer of the Stomach and Cardia: European Organisation for Research and Treatment of Cancer Randomized Trial 40954

2010 507 citations Florian Lordick, Murielle Mauer et al. Journal of Clinical Oncology profile →
Baseline quality of life as a prognostic indicator of survival: a meta-analysis of individual patient data from EORTC clinical trials

2009 488 citations Corneel Coens, Murielle Mauer et al. The Lancet Oncology profile →
Local Treatment of Unresectable Colorectal Liver Metastases: Results of a Randomized Phase II Trial

2017 414 citations Theo J. M. Ruers, Frits van Coevorden et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Murielle Mauer Belgium	31	3.1k	2.8k	1.7k	1.4k	461	86	5.8k
Weiji Shi United States	42	3.5k 1.1×	4.0k 1.4×	2.3k 1.3×	665 0.5×	834 1.8×	98	8.0k
Rosalba Miceli Italy	55	4.5k 1.4×	5.4k 1.9×	2.6k 1.5×	851 0.6×	175 0.4×	251	10.6k
Euan Walpole Australia	32	3.8k 1.2×	2.2k 0.8×	2.2k 1.3×	1.9k 1.3×	115 0.2×	129	6.0k
Sarah Burdett United Kingdom	26	3.6k 1.1×	5.3k 1.9×	1.9k 1.1×	522 0.4×	300 0.7×	56	9.8k
Johannes H.W. de Wilt Netherlands	51	5.9k 1.9×	2.1k 0.7×	4.2k 2.4×	1.2k 0.8×	49 0.1×	320	9.3k
Michael T. Jaklitsch United States	47	2.5k 0.8×	5.6k 2.0×	1.9k 1.1×	204 0.1×	152 0.3×	204	9.3k
David Pérol France	37	2.2k 0.7×	3.4k 1.2×	1.0k 0.6×	106 0.1×	347 0.8×	256	6.1k
Joanne F. Chou United States	29	2.7k 0.9×	917 0.3×	1.1k 0.6×	531 0.4×	231 0.5×	123	4.5k
R. Raab Germany	24	5.6k 1.8×	1.7k 0.6×	4.8k 2.8×	461 0.3×	62 0.1×	49	7.3k
André Konski United States	44	3.7k 1.2×	4.5k 1.6×	3.5k 2.0×	209 0.1×	861 1.9×	228	8.8k

Countries citing papers authored by Murielle Mauer

Since Specialization

Citations

This map shows the geographic impact of Murielle Mauer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Murielle Mauer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Murielle Mauer more than expected).

Fields of papers citing papers by Murielle Mauer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Murielle Mauer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Murielle Mauer. The network helps show where Murielle Mauer may publish in the future.

Co-authorship network of co-authors of Murielle Mauer

This figure shows the co-authorship network connecting the top 25 collaborators of Murielle Mauer. A scholar is included among the top collaborators of Murielle Mauer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Murielle Mauer. Murielle Mauer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Petrillo, Angelica, Lindsey Oudijk, Raghav Sundar, et al.. (2024). EORTC stomach cancer PD-L1 biomarker European initiative: the ASPIRE study protocol. SHILAP Revista de lepidopterología. 5. 100071–100071. 2 indexed citations

Lévy, Antonin, Thierry Berghmans, Michael Koller, et al.. (2024). PRIMALung (EORTC-1901): PRophylactic cerebral irradiation (PCI) or active brain MAgnetic resonance imaging (MRI) surveillance in small-cell lung cancer (SCLC) patients. Lung Cancer. 198. 107993–107993. 6 indexed citations

Wagner, Dorothea, Heike I. Grabsch, Murielle Mauer, et al.. (2023). O-5 Integrating trastuzumab (T), with or without pertuzumab (P), into perioperative chemotherapy (CT) of HER-2+ gastric cancer (GC) - subgroup analyses of EORTC 1203 “INNOVATION”, a collaboration with KCSG and DUCG. Annals of Oncology. 34. S182–S182. 3 indexed citations

Soubeyran, Pierre, Étienne Brain, Kwok‐Leung Cheung, et al.. (2023). Assessing patient-reported outcomes (PROs) and patient-related outcomes in randomized cancer clinical trials for older adults: Results of DATECAN-ELDERLY initiative. Journal of Geriatric Oncology. 15(1). 101611–101611. 12 indexed citations

Leeuwenberg, Artuur, Maarten van Smeden, Johannes A. Langendijk, et al.. (2022). Performance of binary prediction models in high-correlation low-dimensional settings: a comparison of methods. SHILAP Revista de lepidopterología. 6(1). 1–1. 15 indexed citations

Besse, Benjamin, Jessica Menis, Paolo Bironzo, et al.. (2020). LBA85 REACTION: A phase II study of etoposide and cis/carboplatin with or without pembrolizumab in untreated extensive small cell lung cancer. Annals of Oncology. 31. S1211–S1212. 18 indexed citations

Wagner, Dorothea, Sabine Oertelt‐Prigione, Alex A. Adjei, et al.. (2019). Gender medicine and oncology: report and consensus of an ESMO workshop. Annals of Oncology. 30(12). 1914–1924. 132 indexed citations

Piccinin, Claire, Madeline Pe, Francesca Martinelli, et al.. (2019). Prognostic value of patient-reported outcomes from international randomised clinical trials on cancer: a systematic review. The Lancet Oncology. 20(12). e685–e698. 83 indexed citations

Moehler, Markus, Arno Schad, Annett Maderer, et al.. (2018). Lapatinib with ECF/X in the first-line treatment of metastatic gastric cancer according to HER2neu and EGFR status: a randomized placebo-controlled phase II study (EORTC 40071). Cancer Chemotherapy and Pharmacology. 82(4). 733–739. 13 indexed citations

10.

Kataoka, Kozo, Takahiro Kinoshita, Markus Moehler, et al.. (2017). Current management of liver metastases from gastric cancer: what is common practice? New challenge of EORTC and JCOG. Gastric Cancer. 20(5). 904–912. 31 indexed citations

11.

Tanis, E., Catherine Julié, Jean‐François Emile, et al.. (2015). Prognostic impact of immune response in resectable colorectal liver metastases treated by surgery alone or surgery with perioperative FOLFOX in the randomised EORTC study 40983. European Journal of Cancer. 51(17). 2708–2717. 56 indexed citations

12.

Ruers, Theo J. M., C.J.A. Punt, Frits van Coevorden, et al.. (2015). O-018 Radiofrequency ablation (RFA) combined with chemotherapy for unresectable colorectal liver metastases (CRC LM): Long-term survival results of a randomised phase II study of the EORTC-NCRI CCSG-ALM Intergroup 40004 (CLOCC). Annals of Oncology. 26. iv114–iv114. 29 indexed citations

13.

Donneau, Anne‐Françoise, Murielle Mauer, Philippe Lambert, Geert Molenberghs, & A. Albert. (2014). Simulation-Based Study Comparing Multiple Imputation Methods for Non-Monotone Missing Ordinal Data in Longitudinal Settings. Journal of Biopharmaceutical Statistics. 25(3). 570–601. 12 indexed citations

14.

Tanis, E., Bernard Nordlinger, Murielle Mauer, et al.. (2014). Local recurrence rates after radiofrequency ablation or resection of colorectal liver metastases. Analysis of the European Organisation for Research and Treatment of Cancer #40004 and #40983. European Journal of Cancer. 50(5). 912–919. 161 indexed citations

15.

Schmoll, Hans‐Joachim, Karin Haustermans, Timothy Price, et al.. (2013). Preoperative Chemoradiotherapy and Postoperative Chemotherapy with Capecitabine and Oxaliplatin vs. Capecitabine Alone in Locally Advanced Rectal Cancer: Response to the Local Treatment After Chemoradiation and Surgery as Secondary Endpoint. Annals of Oncology. 24. iv120–iv120. 4 indexed citations

16.

Ruers, Theo J. M., Cornelis J.A. Punt, Frits van Coevorden, et al.. (2012). Radiofrequency ablation combined with systemic treatment versus systemic treatment alone in patients with non-resectable colorectal liver metastases: a randomized EORTC Intergroup phase II study (EORTC 40004). Annals of Oncology. 23(10). 2619–2626. 281 indexed citations

17.

Klein, Martin, L. Claassens, Neil K. Aaronson, et al.. (2010). An international validation study of the EORTC brain cancer module (EORTC QLQ-BN20) for assessing health-related quality of life and symptoms in brain cancer patients. European Journal of Cancer. 46(6). 1033–1040. 272 indexed citations

18.

Bolla, M., Geertjan van Tienhoven, Alphonsus C. M. van den Bergh, et al.. (2009). Duration of Androgen Suppression in the Treatment of Prostate Cancer. New England Journal of Medicine. 360(24). 2516–2527. 658 indexed citations breakdown →

19.

Slotman, Ben J., Murielle Mauer, Andrew Bottomley, et al.. (2008). Prophylactic Cranial Irradiation in Extensive Disease Small-Cell Lung Cancer: Short-Term Health-Related Quality of Life and Patient Reported Symptoms—Results of an International Phase III Randomized Controlled Trial by the EORTC Radiation Oncology and Lung Cancer Groups. Journal of Clinical Oncology. 27(1). 78–84. 164 indexed citations

20.

Mauer, Murielle, Roger Stupp, Martin Taphoorn, et al.. (2007). The prognostic value of health-related quality-of-life data in predicting survival in glioblastoma cancer patients: results from an international randomised phase III EORTC Brain Tumour and Radiation Oncology Groups, and NCIC Clinical Trials Group study. British Journal of Cancer. 97(3). 302–307. 91 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact